Rilastil XEROLACT [E] Cream-concentrate 30% lactic acid salt for dry, sensitive, prone to excessive keratinization of the skin, 40 ml
Rilastil XEROLACT [E] Cream-concentrate 30% Lactic Acid Salt: Relief for Dry, Sensitive Skin
Experience the Power of Lactic Acid for Dry, Sensitive Skin
Rilastil XEROLACT [E] Cream-concentrate 30% Lactic Acid Salt is a targeted solution for dry, sensitive skin prone to excessive keratinization. This potent cream effectively reduces hyperkeratosis, restores skin hydration, and strengthens the skin's natural barrier.
Designed for:
- Psoriasis: Provides relief and helps manage symptoms.
- Dryness & Cracks: Intensely moisturizes and heals.
- Xerotic Manifestations: Improves skin texture and reduces roughness.
- Hyperkeratosis: Targets thickened, scaly skin on elbows, knees, heels, and more.
- Ichthyosis: Helps reduce scaling and improve skin appearance.
- Chronic Eczema: Soothes inflammation and supports skin healing.
- Skin Atrophy: Caused by corticosteroids or diabetes, this cream helps restore skin health.
Key Benefits:
- 30% Sodium Lactate: A powerful keratoregulatory ingredient that gently exfoliates and renews skin.
- Vitamin E: Protects against free radical damage and nourishes the skin.
- Shea Butter & Glycerin: Intensely moisturize and enhance skin elasticity.
- Hypoallergenic: Formulated to minimize the risk of allergic reactions.
- Nickel, Cobalt, Chromium, Palladium, and Mercury Tested: Safe for even the most sensitive skin.
- Clinical & Dermatologically Tested: Proven efficacy and safety.
Targeted Therapy:
Rilastil XEROLACT [E] Cream-concentrate 30% Lactic Acid Salt is ideal for:
- Localized Hyperkeratosis: Elbows, knees, heels, etc.
- Follicular Hyperkeratosis: Small bumps on the skin.
- Plantar Hyperkeratosis: Thickened skin on the soles of the feet.
How to Use:
Apply to clean, dry skin twice daily, preferably after bathing or showering.
Precautions:
- Avoid contact with eyes. Rinse thoroughly with water if contact occurs.
- Store in a cool, dry place away from direct heat.